title: A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor.
authors.forename: A
authors.initials: A
authors.lastname: Campanati
authors.forename: R
authors.initials: R
authors.lastname: Berardi
authors.forename: A
authors.initials: A
authors.lastname: Onofri
authors.forename: C
authors.initials: C
authors.lastname: Pierantoni
authors.forename: I
authors.initials: I
authors.lastname: Conte
authors.forename: K
authors.initials: K
authors.lastname: Giuliodori
authors.forename: E
authors.initials: E
authors.lastname: Molinelli
authors.forename: F
authors.initials: F
authors.lastname: Marcucci
authors.forename: S
authors.initials: S
authors.lastname: Cascinu
authors.forename: A
authors.initials: A
authors.lastname: Offidani
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D028241:Camellia sinensis; D004359:Drug Therapy, Combination; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D009536:Niacinamide / Q000008:administration & dosage; D008517:Phytotherapy; D010936:Plant Extracts / Q000008:administration & dosage; D011446:Prospective Studies; D012871:Skin Diseases / Q000139:chemically induced* / Q000188:drug therapy*; D014803:Vitamin B Complex / Q000008:administration & dosage
chemical_list: D000970:Antineoplastic Agents; D010936:Plant Extracts; D014803:Vitamin B Complex; D009536:Niacinamide; D066246:ErbB Receptors